Efficacy and safety of nivolumab in patients with non-clear cell renal cell carcinoma (RCC): Results from the phase IIIb/IV CheckMate 374 study
Vogelzang, Nicholas J., McFarlane, Joshua Jemison, Kochenderfer, Mark D., Molina, Ana M., Arrowsmith, Edward, Bauer, Todd Michael, Hauke, Ralph J., Jain, Rohit, Somer, Bradley G., Lam, Elaine Tat, Doshi, Gurjyot K., Gunuganti, Vijay, Zhang, Joshua, Zhao, Huanyu, Johansen, Jennifer, Tykodi, Scott S.
Published in Journal of clinical oncology (01.03.2019)
Published in Journal of clinical oncology (01.03.2019)
Get full text
Journal Article
A randomized, double-blind, phase II study of first-line FOLFOX plus bevacizumab with onartuzumab versus placebo in patients with metastatic colorectal cancer (mCRC)
Bendell, Johanna C., Hochster, Howard S., Hart, Lowell L., Firdaus, Irfan, Mace, Joseph Ronald, McFarlane, Joshua Jemison, Kozloff, Mark, Catenacci, Daniel Virgil Thomas, Hsu, Jessie J., Hack, Stephen Paul, Shames, David S., Phan, See-Chun, Cohn, Allen Lee
Published in Journal of clinical oncology (20.01.2015)
Published in Journal of clinical oncology (20.01.2015)
Get full text
Journal Article